Juzentaihoto (TJ-48), a traditional Japanese herbal medicine, influences hemoglobin recovery during preoperative autologous blood donation and after hip surgery

International Journal of Clinical Pharmacology and Therapeutics

Volumn 47, Issue 12, 2009, Pages 716-721

  Kishida, Y ^a   Nishii, T ^a   Inoue, T ^a   Nishida, S ^a   Arimitsu, J ^a   Yoshikawa, H ^a   Sugano, N ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Autologous blood donation; Hemoglobin; Hip surgery; Juzentaihoto(TJ 48)

Indexed keywords

ANTIBIOTIC AGENT; HEMOGLOBIN; IRON; LOXOPROFEN; RECOMBINANT ERYTHROPOIETIN; SHI QUAN DA BU TANG;

ANEMIA; ARTICLE; BLEEDING; BLOOD DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL SYMPTOM; HEMOGLOBIN BLOOD LEVEL; HIP OSTEOTOMY; HIP SURGERY; HUMAN; IRON THERAPY; LABORATORY TEST; PERIOPERATIVE PERIOD; PREOPERATIVE CARE; SIDE EFFECT; SURGICAL APPROACH; TOTAL HIP PROSTHESIS;

EID: 71849086859     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP47716     Document Type: Article

References (29)

1. Aksoy MC, Tokgozoglu AM. Erythropoietin for autologous blood donation in total hip arthroplasty patients. Arch Orthop Trauma Surg. 2001; 121: 162-165.
2. Avall A, Hyllner M, Bengtson JP, Carlsson L, Bengtsson A. Recombinant human erythropoietin in preoperative autologous blood donation did not influence the haemoglobin recovery after surgery. Acta Anaesthesiol Scand. 2003; 47: 687-692.
3. Azuma T, Takahashi S, Kawamura A. Preoperative autologous blood donation in hip surgeries. Transfus Sci. 2000; 23: 177-181.
4. Billote DB, Glisson SN, Green D, Wixson RL. Efficacy of preoperative autologous blood donation: analysis of blood loss and transfusion practice in total hip replacement. J Clin Anesth. 2000; 12: 537-542.
5. Billote DB, Glisson SN, Green D, Wixson RL. A prospective, randomized study of preoperative autologous donation for hip replacement surgery. J Bone Joint Surg Am. 2002; 84-A: 1299-1304.
6. Borghi B, Casati A. Incidence and risk factors for allogenic blood transfusion during major joint replacement using an integrated autotransfusion regimen. The Rizzoli Study Group on Orthopaedic Anaesthesia. Eur J Anaesthesiol. 2000; 17: 411-417.
7. Colwell CW, Jr., Chelly JE, Murkin JM, Stevens D, O'Keefe TJ, Hall R, Parvizi J. Randomized study of aprotinin effect on transfusions and blood loss in primary THA. Clin Orthop Relat Res. 2007; 465: 189-195.
8. D'Aubigne RM, Postel M. Function al results of hip arthroplasty with acrylic prosthesis. J Bone Joint Surg Am. 1954; 36-A: 451-475.
9. Deutsch A, Spaulding J, Marcus RE. Preoperative epoetin alfa vs autologous blood donation in primary total knee arthroplasty. J Arthroplasty. 2006; 21: 628-635.
10. Diamond PT, Conaway MR, Mody SH, Bhirangi K. Influence of hemoglobin levels on inpatient rehabilitation outcomes after total knee arthroplasty. J Arthroplasty. 2006; 21: 636-641.
11. Gombotz H, Gries M, Sipurzynski S, Fruhwald S, Rehak P. Preoperative treatment with recombinant human erythropoietin or predeposit of autologous blood in women undergoing primary hip replacement. Acta Anaesthesiol Scand. 2000; 44: 737-742.
12. Guerin S, Collins C, Kapoor H, McClean I, Collins D. Blood transfusion requirement prediction in patients undergoing primary total hip and knee arthroplasty. Transfus Med. 2007; 17: 37-43.
13. Hatzidakis AM, Mendlick RM, McKillip T, Reddy RL, Garvin KL. Preoperative autologous donation for total joint arthroplasty. An analysis of risk factors for allogenic transfusion. J Bone Joint Surg Am. 2000; 82: 89-100.
14. Hisha H, Yamada H, Sakurai MH, Kiyohara H, Li Y, Yu C, Takemoto N, Kawamura H, Yamaura K, Shinohara S, Komatsu Y, Aburada M, Ikehara S. Isolation and identification of hematopoietic stem cell-stimulating substances from Kampo (Japanese herbal) medicine, Juzen-taiho-to. Blood. 1997; 90: 1022-1030.
15. Hisha H, Kohdera U, Hirayama M, Yamada H, Iguchi-Uehira T, Fan TX, Cui YZ, Yang GX, Li Y, Sugiura K, Inaba M, Kobayashi Y, Ikehara S. Treatment of Shwachman syndrome by Japanese herbal medicine (Juzen-taiho-to): stimulatory effects of its fatty acids on hemopoiesis in patients. Stem Cells. 2002; 20: 311-319.
16. Ikegami F, Fujii Y, Ishihara K, Satoh T. Toxicological aspects of Kampo medicines in clinical use. Chem Biol Interact. 2003; 145: 235-250.
17. Keating EM, Callaghan JJ, Ranawat AS, Bhirangi K, Ranawat CS. A randomized, parallel-group, open-label trial of recombinant human erythropoietin vs preoperative autologous donation in primary total joint arthroplasty: effect on postoperative vigor and hand-grip strength. J Arthroplasty. 2007; 22: 325-333.
18. Kogure T, Hoshino A, Ito K, Sato H, Tatsumi T, Ohyama Y, Kawata E, Fujita K, Tamura J. Beneficial effect of complementary alternative medicine on lymphedema with rheumatoid arthritis. Mod Rheumatol. 2005; 15: 445-449.
19. Kubota A, Okamura S, Shimada K, Harada N, Omori F, Niho Y. A traditional chinese herbal medicine, juzentaiho to, augments the production of granunocyte/macrophage colony-stimulating factor from human peripheral blood mononuclear cells in vitro. Int J Immunotherapy. 1992; 8: 191-195.
20. Maruyama Y, Hoshida S, Furukawa M, Ito M. Effects of Japanese herbal medicine, Juzen-taiho-to, in otitisprone children - a preliminary study. Acta Otolaryngol. 2009; 129: 14-18.
21. Mercuriali F, Zanella A, Barosi G, Inghilleri G, Biffi E, Vinci A, Colotti MT. Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion. 1993; 33: 55-60.
22. Nakamoto H, Mimura T, Honda N. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis. Hemodial Int. 2008; 12 (Suppl 2): S9-S14.
23. Price TH, Goodnough LT, Vogler WR, Sacher RA, Hellman RM, Johnston MF, Bolgiano DC, Abels RI. The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trial.Transfusion. 1996; 36: 29-36.
24. Ritter MA. Blood management in total joint replacement: the need for erythropoietin alpha. Orthopedics. 2002; 25: 915.
25. Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, Cremers S, Abraham IL. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003; 43: 459-469.
26. Sho Y, Fujisaki K, Sakashita H, Yamaguchi K, Tahara K, Kubozono O, Ido A, Tsubouchi H. Orally administered Kampo medicine, Juzen-taiho-to, ameliorates anemia during interferon plus ribavirin therapy in patients with chronic hepatitis C. J Gastroenterol. 2004; 39: 1202-1204.
27. Tsuchiya M, Kono H, Matsuda M, Fujii H, Rusyn I. Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress. Int J Cancer. 2008; 123: 2503-2511.
28. Vamvakas EC, Pineda AA. Autologous transfusion and other approaches to reduce allogeneic blood exposure. Baillieres Best Pract Res Clin Haematol. 2000; 13: 533-547.
29. Wang X, Rintala DH, Garber SL, Henson HK. Association of hemoglobin levels, acute hemoglobin decrease, age, and co-morbidities with rehabilitation outcomes after total knee replacement. Am J Phys Med Rehabil. 2005; 84: 451-456; quiz 457-459.